Innate Pharma SA-Spons ADRIPHA
13F holders, Q2 2024 (June 30)8holders −1
1new positions
2sold out
1famous investor
$1.94avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding Innate Pharma SA-Spons ADR (IPHA) in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 2 sold out. The largest holders were Optiver Holding B.V. ($169K), Exchange Traded Concepts, LLC ($167K) and Morgan Stanley ($84K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Innate Pharma SA-Spons ADR
- CUSIP
- 45781K204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $46K |
| Exits | 2 | $72K |
All 13F filers, Q1 2024 → Q2 2024: 40,402 shares bought and 52,566 shares sold, net −12,164 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Optiver Holding B.V. | 0.00% | Add +23.8% | 87,352 | $169K |
| Exchange Traded Concepts, LLC | 0.00% | Reduce -23.7% | 86,237 | $167K |
| Morgan Stanley | 0.00% | Reduce -1.4% | 43,524 | $84K |
| Citadel Advisors | 0.00% | New | 23,527 | $46K |
| Barclays PLC | 0.00% | No change | 412 | $799 |
| UBS Group AG | 0.00% | Add +41.4% | 297 | $576 |
| Rhumbline Advisers | 0.00% | No change | 205 | $397 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 200 | $388 |
"% of holder's portfolio" is IPHA's weight in each manager's 13F, not the share of Innate Pharma SA-Spons ADR the manager owns.